Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.86)
# 358
Out of 4,792 analysts
125
Total ratings
57.8%
Success rate
36.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMA ImageneBio | Initiated Coverage: Buy | $28 | $5.18 | +440.54% | 1 | Aug 21, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $185 | $73.44 | +151.91% | 19 | Aug 17, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $24.90 | $14.03 | +77.51% | 14 | Aug 17, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $125 → $90 | $34.28 | +162.54% | 13 | Aug 12, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $55 | $18.97 | +189.93% | 6 | Aug 11, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $8 | $3.41 | +134.95% | 18 | Aug 10, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $25 | $9.24 | +170.56% | 21 | Aug 10, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $3.25 | +115.38% | 18 | Apr 7, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $16.09 | +5.66% | 3 | Feb 27, 2026 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.026 | n/a | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.93 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27.00 → $35.00 | $28.56 | n/a | 3 | Apr 3, 2023 |
ImageneBio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $5.18
Upside: +440.54%
Nektar Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $185
Current: $73.44
Upside: +151.91%
Satellos Bioscience Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $24.90
Current: $14.03
Upside: +77.51%
Vera Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $125 → $90
Current: $34.28
Upside: +162.54%
Jade Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $55
Current: $18.97
Upside: +189.93%
Prime Medicine
Aug 10, 2026
Reiterated: Buy
Price Target: $8
Current: $3.41
Upside: +134.95%
Solid Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $25
Current: $9.24
Upside: +170.56%
Adagene
Apr 7, 2026
Reiterated: Buy
Price Target: $7
Current: $3.25
Upside: +115.38%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $16.09
Upside: +5.66%
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.026
Upside: n/a
Jun 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $20.93
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $27.00 → $35.00
Current: $28.56
Upside: n/a